Risk factors for suboptimal efficacy of 3-factor prothrombin complex concentrates in emergency VKA anticoagulation reversal

被引：2
|
作者：
Dentali, Francesco [1 ]
Imberti, Davide [2 ]
Permunian, Eleonora Tamburini [1 ]
Croci, Ezio [3 ]
Ageno, Walter [1 ]
机构：
[1] Insubria Univ, Dept Clin Med, Varese, Italy
[2] Piacenza Hosp, Dept Internal Med, Haemostasis & Thrombosis Ctr, Piacenza, Italy
[3] Piacenza Hosp, Piacenza, Italy
来源：
THROMBOSIS AND HAEMOSTASIS | 2014年 / 112卷 / 03期
关键词：
INTERNATIONAL NORMALIZED RATIO; VITAMIN-K ANTAGONISTS; BLEEDING COMPLICATIONS;
D O I：
10.1160/TH13-10-0851
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：621 / 623
页数：3
相关论文
共 50 条
  • [21] Thrombin generation and thromboelastometry in monitoring the in-vitro reversal of warfarin: a comparison between 3-factor and 4-factor prothrombin complex concentrates
    Spiezia, Luca
    Rossetto, Valeria
    Campello, Elena
    Bulato, Cristiana
    Radu, Claudia M.
    Simioni, Paolo
    BLOOD COAGULATION & FIBRINOLYSIS, 2020, 31 (02) : 127 - 131
  • [22] Emergency oral anticoagulant reversal: The necessity for prothrombin complex concentrates
    Makris, M
    Phillips, WS
    Greaves, M
    Kitchen, S
    Rosendaal, FR
    Preston, FE
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 40 - 40
  • [23] Protocolized warfarin reversal with 4-factor prothrombin complex concentrate versus 3-factor prothrombin complex concentrate with recombinant factor VIIa
    Barton, Cassie A.
    Hom, Marissa
    Johnson, Nathan B.
    Case, Jon
    Ran, Ran
    Schreiber, Martin
    AMERICAN JOURNAL OF SURGERY, 2018, 215 (05): : 775 - 779
  • [24] Non-clinical safety and efficacy of prothrombin complex concentrates (PCC) for the reversal of dabigatran mediated anticoagulation
    Herzog, E.
    Kaspereit, F.
    Krege, W.
    Van Joanne, R.
    Dickneite, G.
    Pragst, I
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 693 - 693
  • [25] Discussion of "Protocolized warfarin reversal with 4-factor prothrombin complex concentrate versus 3-factor prothrombin complex concentrate with recombinant factor VIIa"
    Van Dusen, Rachel
    AMERICAN JOURNAL OF SURGERY, 2018, 215 (05): : 780 - 781
  • [26] Emergency reversal of anticoagulation: from theory to real use of prothrombin complex concentrates. A retrospective Italian experience
    Barillari, Giovanni
    Pasca, Samantha
    Barillari, Alfredo
    De Angelis, Vincenzo
    BLOOD TRANSFUSION, 2012, 10 (01) : 87 - 94
  • [27] Use Of Prothrombin Complex Concentrates In Warfarin Anticoagulation Reversal In The Emergency Department: A Quality Improvement Study Of Administration Delays
    Bordeleau, Simon
    Marceau, Daniele
    Poitras, Julien
    Archambeault, Patrick
    Breton, Carolle
    BLOOD, 2013, 122 (21)
  • [28] Emergency reversal of anticoagulation with a three-factor prothrombin complex concentrate in patients with intracranial haemorrhage
    Imberti, Davide
    Barillari, Giovanni
    Blasioli, Chiara
    Bianchi, Marina
    Contino, Laura
    Duce, Rita
    D'Inca, Marco
    Gnani, Maria Cristina
    Mari, Elisa
    Ageno, Walter
    BLOOD TRANSFUSION, 2011, 9 (02) : 148 - 155
  • [29] Emergency oral anticoagulant reversal: The necessity for prothrombin complex concentrates.
    Makris, M
    Phillips, WS
    Greaves, M
    Kitchen, S
    Rosendaal, FR
    Preston, FE
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 22 - 22
  • [30] Use of prothrombin complex concentrates for urgent reversal of dabigatran in the Emergency Department
    Quintana Diaz, Manuel
    Borobia, Alberto M.
    Rivera Nunez, Ma Angelica
    Martinez Virto, Ana Maria
    Fabra, Sara
    Sanchez Casado, Marcelino
    Garcia-Erce, Jose A.
    Meyer Samama, C.
    HAEMATOLOGICA, 2013, 98 (11) : E143 - E144
12345